Search

Your search keyword '"Calandrino, R."' showing total 739 results
Start Over Author "Calandrino, R." Publication Year Range Last 50 years

Refine your results

739 results on '"Calandrino, R."'

1. BriXS, a new X-ray inverse Compton source for medical applications

Author

Cardarelli, P., Bacci, A., Calandrino, R., Canella, F., Castriconi, R., Cialdi, S., Del Vecchio, A., di Franco, F., Drebot, I., Gambaccini, M., Giannotti, D., Loria, A., Mettivier, G., Paternò, G., Petrillo, V., Rossetti Conti, M., Russo, P., Sarno, A., Suerra, E., Taibi, A., and Serafini, L.

Published
2020
Full Text
View/download PDF

14. PD-0539: Chemo-modulation of rectal cancer pathological response: prediction of an early regression index

Author

Broggi, S., primary, Gumina, C., additional, Mori, M., additional, Cattaneo, G.M., additional, Palmisano, A., additional, Di Chiara, A., additional, Ronzoni, M., additional, Slim, N., additional, De Cobelli, F., additional, Calandrino, R., additional, Rosati, R., additional, Di Muzio, N.G., additional, Fiorino, C., additional, and Passoni, P., additional

Published
2020
Full Text
View/download PDF

16. PO-1173: Long term results of IG-IMRT in high risk prostate cancer patients: a monoinstitutional experience

Author

Di Muzio, N., primary, Deantoni, C.L., additional, Cozzarini, C., additional, Dell'Oca, I., additional, Zerbetto, F., additional, Mangili, P., additional, Broggi, S., additional, Pasetti, M., additional, Chiara, A., additional, Borroni, F., additional, Tummineri, R., additional, Perna, L., additional, Calandrino, R., additional, Fiorino, C., additional, and Fodor, A., additional

Published
2020
Full Text
View/download PDF

19. Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer?

Author

Palmisano, A., Esposito, A., Di Chiara, A., Ambrosi, A., Passoni, P., Slim, N., Fiorino, C., Albarello, L., Di Muzio, N., Calandrino, R., Rosati, R., Del Maschio, A., De Cobelli, F., PALMISANO , ANNA, Palmisano, A., Esposito, A., Di Chiara, A., Ambrosi, A., Passoni, P., Slim, N., Fiorino, C., Albarello, L., Di Muzio, N., Calandrino, R., Rosati, R., Del Maschio, A., and De Cobelli, F.

Subjects
Adult, Male, Radiology, Nuclear Medicine and Imaging, Colorectal cancer, Adenocarcinoma, Drug Administration Schedule, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Prospective Studies, Prospective cohort study, Aged, medicine.diagnostic_test, business.industry, Rectal Neoplasms, Cancer, Magnetic resonance imaging, General Medicine, Chemoradiotherapy, Adjuvant, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Oxaliplatin, Tumor Burden, Treatment Outcome, Fluorouracil, 030220 oncology & carcinogenesis, Female, Nuclear medicine, business, Chemoradiotherapy, medicine.drug
Abstract

Aim: To investigate the potential role of an additional magnetic resonance imaging (MRI) examination performed during neoadjuvant chemoradiation therapy (CRT) in the prediction of pathological response in locally advanced rectal cancer (LARC). Material and methods: Forty-eight consecutive patients with LARC underwent neoadjuvant CRT. MRI studies at 1.5 T, including high-resolution T2-weighted sequences that were acquired parallel and perpendicular to the main axis of the tumour were performed before (preMRI), during (midMRI), and 6-8 weeks after the end of CRT (postMRI). Cancer volumes (Vpre, Vmid, Vpost) were drawn manually and the reduction rate calculated (ΔVmid, ΔVpost). According to Rödel's pathological tumour regression grade (TRG), patients were considered non-responders (NR; TRG0-2), partial responders (PR; TRG3), and complete responders (CR; TRG4). Multivariate regression analysis was performed to identify the best MRI predictors of NR, PR, and CR. Results: Twenty-five patients were considered PR (52%), 13 CR (27%), and 10 NR (22%). Tumour shrinkage mainly occurred shortly after CRT (ΔVmid: CR: 80±10% versus PR: 56±19% versus NR: 28±22%, p=2.2×10-16). Vmid, Vpost, ΔVmid, and ΔVpostcorrelated with TRG (p

Published
2017

20. Multi Colour X-Gamma Ray Inverse Compton Back-Scattering Source

Author

Drebot, I., Giannotti, D., Serafini, L., Cialdi, S., Petrillo, V., Cardarelli, P., Gambaccini, M., Paternó, G., Taibi, A., Calandrino, R., Delvecchio, A., and Galzerano, G.

Subjects
electron, radiation, laser, electron, radiation, photon, cavity, A24 Accelerators and Storage Rings, Other, photon, 02 Photon Sources and Electron Accelerators, cavity, Accelerator Physics, NO, laser
Abstract

We present a simple and new scheme for producing multi colour Thomson/Compton radiation with the possibility of controlling separately their polarization, based on the interaction of one single electron beam with two and more laser pulses that can come from the same laser setup or from two different lasers system and that collide with the electrons at different angle inside one optical cavity. One of the most interesting cases for medical applications is to provide two X-ray pulses across the iodine K-edge at 33.2 keV. The iodine is used as contrast medium in various imaging techniques and the availability of two spectral lines accross the K-edge allows one to produce subtraction images with a great increase in accuracy., Proceedings of the 9th Int. Particle Accelerator Conf., IPAC2018, Vancouver, BC, Canada

Published
2018

21. MariX, an advanced MHz-class repetition rate X-ray source for linear regime time-resolved spectroscopy and photon scattering

Author

Serafini, L., primary, Bacci, A., additional, Bellandi, A., additional, Bertucci, M., additional, Bolognesi, M., additional, Bosotti, A., additional, Broggi, F., additional, Calandrino, R., additional, Camera, F., additional, Canella, F., additional, Capra, S., additional, Cardarelli, P., additional, Carrara, M., additional, Cassou, K., additional, Castoldi, A., additional, Castriconi, R., additional, Cattaneo, G.M., additional, Cialdi, S., additional, Cianchi, A., additional, Coluccelli, N., additional, Curatolo, C., additional, Del Vecchio, A., additional, Di Mitri, S., additional, Drebot, I., additional, Dupraz, K., additional, Esposito, A., additional, Faillace, L., additional, Ferrario, M., additional, Fiorini, C., additional, Galzerano, G., additional, Gambaccini, M., additional, Ghiringhelli, G., additional, Giannotti, D., additional, Giove, D., additional, Groppi, F., additional, Guazzoni, C., additional, Laporta, P., additional, Leoni, S., additional, Loria, A., additional, Mangili, P., additional, Martens, A., additional, Mazza, T., additional, Mazzotta, Z., additional, Meroni, C., additional, Mettivier, G, additional, Michelato, P., additional, Monaco, L., additional, Morante, S., additional, Moretti Sala, M., additional, Nutarelli, D., additional, Olivares, S., additional, Onida, G., additional, Opromolla, M., additional, Pagani, C., additional, Paparella, R., additional, Paris, M.G.A., additional, Paroli, B., additional, Paternò, G., additional, Paulin, C., additional, Perini, L., additional, Petrarca, M., additional, Petrillo, V., additional, Pinotti, E., additional, Piseri, P., additional, Potenza, M.A.C., additional, Prelz, F., additional, Pullia, A., additional, Puppin, E., additional, Ragusa, F., additional, Ramponi, R., additional, Romè, M., additional, Rossetti Conti, M., additional, Rossi, A.R., additional, Rossi, L., additional, Ruijter, M., additional, Russo, P., additional, Samsam, S., additional, Sarno, A., additional, Sertore, D., additional, Sorbi, M., additional, Spataro, B., additional, Statera, M., additional, Stellato, F., additional, Suerra, E., additional, Tagliaferri, A., additional, Taibi, A., additional, Torri, V., additional, Turchetti, G., additional, Vaccarezza, C., additional, Valdagni, R., additional, Vanzulli, A., additional, Zomer, F., additional, and Rossi, G., additional

Published
2019
Full Text
View/download PDF

26. PO-0816 Adaptive radiotherapy concomitant with chemotherapy as preoperative treatment for rectal cancer

Author

Passoni, P., primary, Slim, N., additional, Fiorino, C., additional, Gumina, C., additional, Ronzoni, M., additional, Burgio, V., additional, Fasolo, A., additional, De Cobelli, F., additional, Palmisano, A., additional, Elmore, U., additional, De Nardi, P., additional, Tamburini, A.M., additional, Vignali, A., additional, Rosati, R., additional, Calandrino, R., additional, and Di Muzio, N., additional

Published
2019
Full Text
View/download PDF

34. Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I–II study

Author

Cozzarini C, Fiorino C, Di Muzio N, Valdagni R, SALONIA , ANDREA, Alongi F, Broggi S, Guazzoni G, MONTORSI , FRANCESCO, Rigatti P, Calandrino R, Fazio F., DI MUZIO, NADIA GISELLA, Cozzarini, C, Fiorino, C, Di Muzio, N, Valdagni, R, Salonia, A, Alongi, F, Broggi, S, Guazzoni, G, Montorsi, F, Rigatti, P, Calandrino, R, Fazio, F, Salonia, Andrea, Montorsi, Francesco, Fazio, F., and DI MUZIO, NADIA GISELLA

Subjects
Male, medicine.medical_specialty, Radiotherapy planning, Urethral stricture, medicine.medical_treatment, Urology, Radiography, Interventional, Tomotherapy, Prostate cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, Dose Fractionation, Tomography, Adjuvant, Proctitis, Analysis of Variance, Chi-Square Distribution, Radiation, Adjuvant radiotherapy, Toxicity, Dose Fractionation, Radiation, Feasibility Studies, Prostatic Neoplasms, Radiotherapy Dosage, Radiotherapy, Adjuvant, Treatment Outcome, Tomography, Spiral Computed, Radiotherapy, Interventional, business.industry, Prostatectomy, Hematology, medicine.disease, Acute toxicity, Surgery, Radiography, Regimen, Oncology, Spiral Computed, business
Abstract

Purpose: To report on planning and toxicity findings of hypofractionated adjuvant radiotherapy with helical Tomotherapy (HTT) after radical prostatectomy (RP) for prostate carcinoma (pCa). Methods and materials: Fifty consecutive patients submitted to RP for pT2R1/pT3a/pT3b-pN0 pCa were enrolled in a Phase I-II trial to receive 58 Gy/20 fractions (5/week) on tumoral bed. Endpoint was to verify a risk of toxicity and biochemical failure not exceeding that observed in our Institutional 3DCRT, conventionally fractionated series (15 3 patients). Toxicities were graded according the RTOG scoring system. Results: Excellent coverage of PTV and high homogeneity of dose distribution were always achieved. Median follow-up was 25 months. Acute G2-3 RTOG genitourinary (GU) and acute G2 intestinal toxicities were similar (12% vs 15.6% and 4% vs 7%, respectively), while acute G2 proctitis was 0% vs 9% in HTT and 3DCRT group, respectively. Similarly, late Grade >= 2 gastrointestinal sequelae were 0% vs 8.5%. The incidence of late urethral stricture, 8% and 9% in HTT and 3DCRT group, respectively, is comparable to that of RP-only series. Conclusions: Acute toxicity and early late toxicity outcomes of a moderately hypofractionated regimen with HTT post-RP are excellent. A longer follow-up is needed to fully assess the validity of this approach. (c) 2008 Elsevier Ireland Ltd. All rights reserved. Purpose: To report on planning and toxicity findings of hypofractionated adjuvant radiotherapy with helical Tomotherapy (HTT) after radical prostatectomy (RP) for prostate carcinoma (pCa). Methods and materials: Fifty consecutive patients submitted to RP for pT2R1/pT3a/pT3b-pN0 pCa were enrolled in a Phase I-II trial to receive 58 Gy/20 fractions (5/week) on tumoral bed. Endpoint was to verify a risk of toxicity and biochemical failure not exceeding that observed in our Institutional 3DCRT, conventionally fractionated series (15 3 patients). Toxicities were graded according the RTOG scoring system. Results: Excellent coverage of PTV and high homogeneity of dose distribution were always achieved. Median follow-up was 25 months. Acute G2-3 RTOG genitourinary (GU) and acute G2 intestinal toxicities were similar (12% vs 15.6% and 4% vs 7%, respectively), while acute G2 proctitis was 0% vs 9% in HTT and 3DCRT group, respectively. Similarly, late Grade >= 2 gastrointestinal sequelae were 0% vs 8.5%. The incidence of late urethral stricture, 8% and 9% in HTT and 3DCRT group, respectively, is comparable to that of RP-only series. Conclusions: Acute toxicity and early late toxicity outcomes of a moderately hypofractionated regimen with HTT post-RP are excellent. A longer follow-up is needed to fully assess the validity of this approach. (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Published
2008

37. EP-1390: Salvage (postponed) hypofractionated tomotherapy for progressive MPM in patients with intact lungs

Author

Fodor, A., primary, Broggi, S., additional, Incerti, E., additional, Dell'Oca, I., additional, Fiorino, C., additional, Samanes Gajate, A.M., additional, Passoni, P., additional, Pasetti, M., additional, Cattaneo, M.G., additional, Gianolli, L., additional, Calandrino, R., additional, Picchio, M., additional, and Di Muzio, N.G., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results